Clinical Trials Industry News More
-
Abbott And GSK To Collaborate On Molecular Diagnostic Test To Select Candidate Patients For Future Cancer Immunotherapy
7/14/2009
Abbott announced recently that it has entered into an agreement with GlaxoSmithKline (GSK) to develop an automated molecular diagnostic test, based on polymerase chain reaction (PCR) technology, intended to screen non-small cell lung cancer (NSCLC) tumors for expression of the MAGE-A3 antigen.
-
WHO Grants Prequalification To Cervarix: GSK’s Vaccine To Help Combat Cervical Cancer In Developing Nations
7/14/2009
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline’s cervical cancer vaccine. The WHO decision is necessary for UN agencies and the GAVI Alliance to purchase the vaccine in partnership with developing countries and will help speed access to Cervarix globally.
-
High Throughput Monitoring Of Protein Adsorption
7/14/2009
Paraytec Ltd. has announced that its multi-award winning ActiPix D-100 system has been selected by Cambridge University to enable pioneering research into high-throughput micro channel separations of recombinant proteins within microcapillary films.
-
DIA Workshop Features Industry And FDA For Discussion Of Best Practices For Electronic Establishment Registration And Product Listing
7/9/2009
The Drug Information Association (DIA), in collaboration with the Generic Pharmaceutical Association (GPhA), PhRMA, and the Consumer Healthcare Products Association (CHPA), will host eDrug Listing and Establishment Registration: Overview and Lessons Learned on SPL (August 11-12; Philadelphia, PA).
-
Purdue Researchers Create Prostate Cancer 'Homing Device' For Drug Delivery
7/7/2009
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease.
-
Online Reporting System For Swine Flu Antiviral Side Effects
7/7/2009
Suspected side effects to swine flu antiviral medicines can now be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via a new dedicated webpage.
-
Novasep Acquires Bioprocess Development Specialist And Contract Manufacturer Henogen
7/7/2009
Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces recently the acquisition of Henogen, a contract manufacturing organization (CMO) offering bioprocess development and manufacturing services from the cell bank to the supply of clinical products.
-
R&D Logic's Unique Products And Services Offering Gaining Momentum With Leading Life Sciences Companies
7/3/2009
R&D Logic, preferred provider of web based business management software specific to the Life Sciences Industry, today announced five new additions to their Life Sciences Customer Community.
-
Biologics Dominate The Autoimmune Market But Small Molecules Still Have Some Fight Left, Says Cutting Edge Information
7/1/2009
Biological drugs are the big winners in the market for autoimmune disorders.
-
Early Stage Process Development - Florida Biologix® Expands Team
6/30/2009
Florida Biologix is a unique contract manufacturing organization capable of helping companies get products through proof of concept and phase I studies quickly and at reasonable cost.
This website uses cookies to ensure you get the best experience on our website. Learn more